Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical (LFCR) Other Working Capital Changes: 2010-2025

Historic Other Working Capital Changes for Lifecore Biomedical (LFCR) over the last 16 years, with May 2025 value amounting to -$378,000.

  • Lifecore Biomedical's Other Working Capital Changes fell 85.52% to -$1.6 million in Q2 2025 from the same period last year, while for May 2025 it was -$378,000, marking a year-over-year increase of 86.76%. This contributed to the annual value of -$378,000 for FY2025, which is 86.76% up from last year.
  • Per Lifecore Biomedical's latest filing, its Other Working Capital Changes stood at -$378,000 for FY2025, which was up 86.76% from -$2.9 million recorded in FY2024.
  • In the past 5 years, Lifecore Biomedical's Other Working Capital Changes registered a high of $689,000 during FY2022, and its lowest value of -$8.3 million during FY2021.
  • Moreover, its 3-year median value for Other Working Capital Changes was -$2.2 million (2023), whereas its average is -$1.8 million.
  • Per our database at Business Quant, Lifecore Biomedical's Other Working Capital Changes skyrocketed by 108.32% in 2022 and then tumbled by 412.92% in 2023.
  • Over the past 5 years, Lifecore Biomedical's Other Working Capital Changes (Yearly) stood at -$8.3 million in 2021, then soared by 108.32% to $689,000 in 2022, then crashed by 412.92% to -$2.2 million in 2023, then slumped by 32.37% to -$2.9 million in 2024, then soared by 86.76% to -$378,000 in 2025.